Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Sabroe

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Clinical and Experimental Dermatology|November 21, 2009
Failure of omalizumab in cholinergic urticariaR A Sabroe
The British Journal of Dermatology|February 1, 2020
Ligelizumab for chronic spontaneous urticariaR A Sabroe
The British Journal of Dermatology|July 29, 2014
Commentary: Omalizumab for the treatment of chronic idiopathic or spontaneous urticariaR A Sabroe
Clinical and Experimental Dermatology|May 8, 1999
Scombrotoxic fish poisoningR A Sabroe, A Kobza Black
The Journal of Dermatology|November 1, 1996
Histamine: the quintessential mediatorM W Greaves, R A Sabroe
Clinical and Experimental Dermatology|January 1, 1996
Facial granulomatous lymphoedema and syringomyeliaR A Sabroe, C T Kennedy
Archives of Dermatology|August 1, 1997
The pathogenesis of chronic idiopathic urticariaR A Sabroe, M W Greaves
BMJ (Clinical Research Ed.)|April 29, 1998
ABC of allergies. Allergy and the skin. I--UrticariaM W Greaves, R A Sabroe
The British Journal of Dermatology|February 1, 1997
Angiotensin-converting enzyme (ACE) inhibitors and angio-oedemaR A Sabroe, A K Black
The British Journal of Dermatology|April 26, 2006
Chronic idiopathic urticaria with functional autoantibodies: 12 years onR A Sabroe, M W Greaves
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Clinical and Experimental Dermatology|November 21, 2009
Failure of omalizumab in cholinergic urticariaR A Sabroe
The British Journal of Dermatology|February 1, 2020
Ligelizumab for chronic spontaneous urticariaR A Sabroe
The British Journal of Dermatology|July 29, 2014
Commentary: Omalizumab for the treatment of chronic idiopathic or spontaneous urticariaR A Sabroe
Clinical and Experimental Dermatology|May 8, 1999
Scombrotoxic fish poisoningR A Sabroe, A Kobza Black
The Journal of Dermatology|November 1, 1996
Histamine: the quintessential mediatorM W Greaves, R A Sabroe
Clinical and Experimental Dermatology|January 1, 1996
Facial granulomatous lymphoedema and syringomyeliaR A Sabroe, C T Kennedy
Archives of Dermatology|August 1, 1997
The pathogenesis of chronic idiopathic urticariaR A Sabroe, M W Greaves
BMJ (Clinical Research Ed.)|April 29, 1998
ABC of allergies. Allergy and the skin. I--UrticariaM W Greaves, R A Sabroe
The British Journal of Dermatology|February 1, 1997
Angiotensin-converting enzyme (ACE) inhibitors and angio-oedemaR A Sabroe, A K Black
The British Journal of Dermatology|April 26, 2006
Chronic idiopathic urticaria with functional autoantibodies: 12 years onR A Sabroe, M W Greaves
Pageof 4